alexa Research-in-pharmacogenomics|OMICS International|Journal Of Pharmacogenomics And Pharmacoproteomics

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Research In Pharmacogenomics

The goal of pharmacogenomics is to aid in individualized treatment (precision medicine). Pharmacogenomics now plays an increasingly important role in the process of drug development. Pharmacogenomics-informed treatment has the potential to increase the efficacy of commonly used therapeutics in hospital settings, while greatly reducing adverse drug reactions. Over the past few years, genetic polymorphisms in proteins involved in metabolism or transport have now been identified as clinically relevant, explaining differences in efficacy and impacting clinical care. Single nucleotide polymorphisms (SNPs) are the most commonly observed variants, and are responsible for greater than ninety percent of all genetic variation in the human genome. The Clinical Center at the National Institutes of Health has recently implemented pharmacogenetics testing in patients receiving certain medications. It is therefore important to review and understand the molecular and physiological basis for gene-drug interactions, and appreciate the impact on drug therapy and precision medicine. Douglas K. Price, Pharmacogenomics and precision medicine: From laboratory to clinical practice.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on June, 2014